This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Romania, Spain.
The drug LOCAMETZ contains one active pharmaceutical ingredient (API):
1
|
UNII
ZJ0EKR6M10 - GALLIUM GA-68 GOZETOTIDE
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| LOCAMETZ Kit for radiopharmaceutical preparation | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V09IX14 | V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1891953 |
| ES | Centro de información online de medicamentos de la AEMPS | 1221692001 |
| FR | Base de données publique des médicaments | 67475965 |
| IT | Agenzia del Farmaco | 050420013 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1096124 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W69481001 |
| US | FDA, National Drug Code | 69488-017 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.